HUAYAN ROBOTICS (01021) released its mid-term performance report, with revenue of 174 million yuan, an increase of 0.59% year-on-year.
Huayan Robotics (01021) announced its interim results for the six months ending June 30, 2026, reporting revenues of RMB 174 million, an increase of 0.59% year-on-year; a loss attributable to shareholders of the parent company amounting to RMB 56.904 million; research and development expenses of RMB 35.769 million, an increase of 18.41% year-on-year; and a loss per share of RMB 0.11.
HUAYAN ROBOTICS (01021) announced its interim results for the six months ending June 30, 2026. The group achieved revenue of RMB 174 million, an increase of 0.59% year-on-year; the loss attributable to the owners of the parent company was RMB 56.904 million; research and development expenses amounted to RMB 35.769 million, an increase of 18.41% year-on-year; and the loss per share was RMB 0.11.
During the reporting period, the group made deep investments in the field of embodied intelligence, focusing on core motion components for embodied intelligence. It is building a high-performance, integrated core product platform around the humanoid Siasun Robot & Automations motion execution layer, creating a product system that covers core components, execution systems, and motion control capabilities. As the commercialization continues to accelerate, the group will solidify its advantages as a core upstream supplier in embodied intelligence, continually increasing investment to fully embrace the era of embodied intelligence with a complete range of product forms.
As of the date of this announcement, the group has completed the establishment of its subsidiary in Germany and has initiated local deployments in North America and Asia. Moving forward, it will continue to focus on its globalization development strategy, increasing investment in overseas market resources and channel system construction. It will further deepen localized operations and service capabilities in core regions such as Europe, North America, and Asia-Pacific, enhancing the service network of overseas subsidiaries and offices. At the same time, by continuously improving product performance, safety standards, and cost-effectiveness, and strengthening the after-sales service system, it aims to gain broad recognition and customer loyalty from major overseas clients, thereby continuously promoting the replication and marketing of the groups advantageous products in overseas markets, accelerating the process of brand internationalization, and enhancing international competitiveness to achieve scaled expansion in overseas markets.
Related Articles

HK Stock Market Move | SHINEWAY PHARM (02877) soared 12% in the afternoon, with first-half performance down more than 20%. It plans to distribute a second interim dividend of 80 cents.

HK Stock Market Move | WASION HOLDINGS (03393) saw a plunge of over 15% in the afternoon, with a year-on-year increase of only 1.41% in net profit for the first half of the year, and an overall gross profit margin falling to 31.28%.

MIXUE GROUP (02097) achieved revenue of approximately 15.216 billion yuan in the first half of the year, a year-on-year increase of 2.3%. The global store network continues to expand.
HK Stock Market Move | SHINEWAY PHARM (02877) soared 12% in the afternoon, with first-half performance down more than 20%. It plans to distribute a second interim dividend of 80 cents.

HK Stock Market Move | WASION HOLDINGS (03393) saw a plunge of over 15% in the afternoon, with a year-on-year increase of only 1.41% in net profit for the first half of the year, and an overall gross profit margin falling to 31.28%.

MIXUE GROUP (02097) achieved revenue of approximately 15.216 billion yuan in the first half of the year, a year-on-year increase of 2.3%. The global store network continues to expand.

RECOMMEND





